• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MSB 12.1% 55.5¢

MESOBLAST LIMITED

Mesoblast Limited is an Australia-based is developing a range of late-stage product... Mesoblast Limited is an Australia-based is developing a range of late-stage product candidates derived from its proprietary mesenchymal lineage cell therapy technology platforms. The Company’s Remestemcel-L is mesenchymal lineage stromal cell product platform and is in late-stage development for treatment of systemic inflammatory diseases, including Pediatric steroid refractory acute Graft versus Host Disease (SR-aGVHD), acute respiratory distress syndrome (ARDS) and Biologic refractory inflammatory bowel disease. Its Rexlemestrocel-L is mesenchymal lineage precursor cell product platform and is in late-stage development for treatment of advanced chronic heart failure (CHF) and chronic low back pain (CLBP) due to degenerative disc disease. Two products are commercialized in Japan and Europe by the Company’s licensees, and it has a commercial partnership in Europe and China for certain Phase III assets.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MSB
banter and General Discussion
21:42 9.3K 2.6M
21:42 Last post  Goldfarm Comments Created with Sketch.  9.3K  Views Created with Sketch.  2.6M 
MSB
MESO Nasdaq update
80 81 82
20:47 4.9K 2.3M
20:47 Last post  Kingtup Comments Created with Sketch.  4.9K  Views Created with Sketch.  2.3M 
MSB 20:05 460 144K
20:05 Last post  csrwin Comments Created with Sketch.  460  Views Created with Sketch.  144K 
MSB
NASDAQ hot!!!
2 3 4
17:01 212 82K
17:01 Last post  dyode Comments Created with Sketch.  212  Views Created with Sketch.  82K 
MSB
CEO Itescu needs to go
14 15 16
14:16 904 273K
14:16 Last post  ChewingHands Comments Created with Sketch.  904  Views Created with Sketch.  273K 
MSB 11:31 248 84K
11:31 Last post  nippy Comments Created with Sketch.  248  Views Created with Sketch.  84K 
MSB
MSB Charts
2
28/03/24 78 35K
28/03/24 Last post  Mikesmith1981 Comments Created with Sketch.  78  Views Created with Sketch.  35K 
MSB 28/03/24 154 44K
28/03/24 Last post  gavint66 Comments Created with Sketch.  154  Views Created with Sketch.  44K 

See All Discussions arrow Created with Sketch.

Timeline

FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
26 Mar 13:05
 
Pause in Trading
26 Mar 09:52
 
Cleansing Notice
26 Mar 09:48
 
Application for quotation of securities - MSB
22 Mar 16:32
 
Change in substantial holding
20 Mar 09:46
 
Proposed issue of securities - MSB
20 Mar 09:37
 
View More arrow Created with Sketch.
(20min delay)
Last
55.5¢
Change
0.060(12.1%)
Mkt cap ! $633.0M
Open High Low Value Volume
50.0¢ 59.0¢ 48.5¢ $16.88M 30.80M

Buyers (Bids)

No. Vol. Price($)
4 62700 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 40000 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
55.5¢
  Change
0.060 ( 15.7 %)
Open High Low Volume
50.5¢ 59.0¢ 48.5¢ 11524458
Last updated 16.02pm 29/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.